Literature DB >> 1644438

Distribution of basement membranes in primary and metastatic carcinomas of the prostate.

H Bonkhoff1, N Wernert, G Dhom, K Remberger.   

Abstract

The presence of periacinar and pericellular basement membranes (BMs) has been reported recently in common prostatic adenocarcinomas. In this study we extended our investigations of BMs on lymph node and hematogenous metastases, primary prostatic cancer with unusual histologic features, and posttreatment tumors. In contrast to prostatic malignancies that derive from the transitional epithelium (squamous cell carcinoma, prostatic transitional cell carcinoma) and prostatic involvement by bladder cancer, inconspicuous stromal changes and distinct BM formations at the site of tumor invasion were observed in carcinomas deriving from the secretory epithelium (papillary ductal carcinoma) and from the basal cell (basal cell carcinoma). Even highly malignant anaplastic and small cell carcinomas, as well as irradiated and/or hormonally treated tumors, showed distinct BM formations in contact with the stroma. The same observations could be made in lymphatic and hematogenous metastases of different anatomic sites. These findings indicate that prostatic malignancies may retain BMs even in high-grade lesions, metastases, posttreatment tumors, and variants of prostatic adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644438     DOI: 10.1016/0046-8177(92)90408-u

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.

Authors:  P Dehan; D Waltregny; A Beschin; A Noel; V Castronovo; K Tryggvason; J De Leval; J M Foidart
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 2.  Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.

Authors:  Jijing Luo; Xiaoqi Liu
Journal:  Protein Cell       Date:  2012-03-23       Impact factor: 14.870

3.  Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate.

Authors:  J D Knox; A E Cress; V Clark; L Manriquez; K S Affinito; B L Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

4.  A human xenograft model for testing early events of epithelial neoplastic invasion.

Authors:  J McCandless; A Cress; I Rabinovitz; C Payne; G Bowden; J Knox; R Nagle
Journal:  Int J Oncol       Date:  1997-02       Impact factor: 5.650

5.  Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

Authors:  Alessandro Sgambato; Mario Migaldi; Micaela Montanari; Andrea Camerini; Andrea Brancaccio; Giulio Rossi; Rodolfo Cangiano; Carmen Losasso; Giovanni Capelli; Gian Paolo Trentini; Achille Cittadini
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 6.  The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression.

Authors:  A E Cress; I Rabinovitz; W Zhu; R B Nagle
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.